Version française  
MIT
MIT
 
Injection Home Products Research & Dev News About Us Contact Us
 

Medical International Technology Inc Financials
Thursday, February 20th 2014
Annual Data All numbers in thousands
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011
Total Revenue 847   996   437  
Cost of Revenue 214   259   201  
Gross Profit 633   737   237  
Operating Expenses
Research Development -   -   -  
Selling General and Administrative 563   710   702  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 70   27   (466)
Income from Continuing Operations
Total Other Income/Expenses Net 1,073   -   -  
Earnings Before Interest And Taxes 996   (68) (596)
Interest Expense 13   42   47  
Income Before Tax 983   (110) (643)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops 836   (206) (774)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 983   (110) (643)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 983   (110) (643)

 

Quarterly Data All numbers in thousands
Period Ending Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Total Revenue 25   318   125   290  
Cost of Revenue 20   47   45   70  
Gross Profit 5   271   79   221  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative 98   23   103   204  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (93) 248   (23) 17  
Income from Continuing Operations
Total Other Income/Expenses Net 0   1,072   0   0  
Earnings Before Interest And Taxes (93) 1,174   112   (118)
Interest Expense 3   1   3   6  
Income Before Tax (96) 1,172   110   (124)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops (96) 1,170   100   (178)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (96) 1,317   (35) (42)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (96) 1,317   (35) (42)